S15 - Intracerebral Hemorrhage and SAH
Event Time: | Monday May 6, 2019 1:00 pm to 3:00 pm |
Topic(s): | Cerebrovascular Disease and Interventional Neurology |
Director(s): | |
Description: | |
Completion Message: | |
CME Credits: | 2 |
Core Competencies: |
Start/End Time | Title | Faculty |
---|---|---|
2:40 PM - 3:00 PM | Q&A Panel with Authors | Faculty |
Speaker | Disclosure |
---|
Start Time | Pub. | Title | Presenter |
---|---|---|---|
1:00 PM | 001 | Warfarin use, intensity of anticoagulation, and occurrence of intracerebral hemorrhage in stroke patients: An analysis of Taiwan Stroke Registry data |
Disclosure: Dr. Qureshi has nothing to disclose.
|
1:00 PM | 002 | Risk of Intracerebral Hemorrhage in Pregnancy and the Postpartum Period: A Population Based Analysis using a Cohort–Cross Over Design |
Disclosure: Dr. Meeks has nothing to disclose.
|
1:00 PM | 003 | Soluble ST2 Predicts Functional Outcome after Spontaneous Intracerebral Hemorrhage |
Disclosure: Dr. Li has nothing to disclose.
|
1:00 PM | 004 | CSF Inflammatory and Vasoactive Mediators Associated with Poor Functional Outcome in Subarachnoid Hemorrhage (SAH) Patients. |
Disclosure: Dr. Saand has nothing to disclose.
|
1:00 PM | 005 | Racial/Ethnic Disparities in the Risk of Intracerebral Hemorrhage Recurrence |
Disclosure: Dr. Leasure has nothing to disclose.
|
1:00 PM | 006 | Effect of Age In The Outcomes Of Patients Undergoing Treatment Of Unruptured Intracranial Aneurysms: A Study Of the National Inpatient Sample 2009-2014 |
Disclosure: Dr. Khatri has nothing to disclose.
|
1:00 PM | 007 | Baseline Characteristics and Readmissions Analysis in Younger and Older Adults with Intracerebral Hemorrhage |
Disclosure: Dr. Kim has nothing to disclose.
|
1:00 PM | 008 | Predicting Functional Outcomes Using Radiographic Characteristics of Spontaneous ICH-Mediated Encephalomalacia (IME) in the MISTIE-II Cohort |
Disclosure: Dr. Ali has nothing to disclose.
|
1:00 PM | 009 | In-hospital Delirium and Long-Term Cognitive Outcomes among Patients with Intracerebral Hemorrhage: A population-based cohort analysis |
Disclosure: Dr. Meeks has nothing to disclose.
|
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
9:30 AM-11:30 AM |
---|
C16 -
Cerebrovascular Disease I: Prevention
Larry Goldstein MD, FAAN, FAHA |
1:30 PM-3:30 PM |
C27 -
Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke
Andrew Naidech MD, FAAN |
7:00 AM-9:00 AM |
---|
C40 -
Child Neurology: Stroke
Lori Billinghurst MD |
11:30 AM-6:30 PM |
P1 -
Poster Session 1
|
1:00 PM-3:00 PM |
C50 -
Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke
Johanna Fifi MD, FAAN |
3:30 PM-5:30 PM |
C68 -
Cerebrovascular Disease IV: Telestroke
Eric Anderson MD, PhD |
C72 -
Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease
LynnMarie Trotti MD |
7:00 AM-9:00 AM |
---|
C82 -
Stroke in Young Adults and Women
Aneesh Singhal MD, FAAN |
9:15 AM-12:00 PM |
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
11:30 AM-6:30 PM |
P2 -
Poster Session 2
|
1:00 PM-3:00 PM |
3:30 PM-5:30 PM |
C109 -
Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies
Ralph Jozefowicz MD, FAAN, Adam Quick MD |
C119 -
Actualización en lesión cerebral traumática e ictus isquémico (Update: TBI and Stroke)
Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN |
S19 -
Child Neurology: Updates in Autism, Migraine, MS, and Stroke
|
S22 -
Stroke Genetics, Cellular Responses, and Animal Models
|
7:00 AM-9:00 AM |
---|
C124 -
Endovascular Treatment of Acute Stroke and Cerebrovascular Disease
Dileep Yavagal MD, FAAN |
11:30 AM-6:30 PM |
P3 -
Poster Session 3
|
1:00 PM-3:00 PM |
C135 -
Case Studies: Challenging Acute Ischemic Stroke Cases
Vivien Lee MD, FAAN |
3:30 PM-5:30 PM |
C164 -
Update on Medical Management of Stroke
Adam De Havenon MD |
7:00 AM-9:00 AM |
---|
C165 -
Current Management of Incidental and Asymptomatic Cerebrovascular Lesions
Robert Brown MD, FAAN |
11:30 AM-6:30 PM |
P4 -
Poster Session 4
|
1:00 PM-3:00 PM |
S35 -
Stroke Prevention Strategies
|
3:30 PM-5:30 PM |
S40 -
Stroke Risk Factors and Epidemiology
|
7:00 AM-9:00 AM |
---|
C214 -
Child Neurology: A Case-based Approach
Elaine Wirrell MD, FAAN |
9:15 AM-11:30 AM |
Controversies in Neurology Plenary Session
Amy Brooks-Kayal MD, FAAN, Aleksandar Videnovic MD, MSc, FAAN |
11:30 AM-6:30 PM |
P5 -
Poster Session 5
|
1:00 PM-3:00 PM |
S47 -
Stroke Outcomes and Recurrence
|
3:30 PM-5:30 PM |
C233 -
Therapy in Neurology IV: Movement Disorders and Stroke
David Dodick MD, FAAN |
S52 -
Acute Non-Interventional Stroke Care
|
7:00 AM-9:00 AM |
---|
C245 -
Controversies in Stroke Treatment and Prevention
Pierre Fayad MD, FAAN, FAHA |
11:45 AM-12:45 PM |
Friday Grand Finale: Neuroimaging
|
1:00 PM-3:00 PM |
S57 -
Acute Treatment and Imaging of Ischemic Stroke
|